The Hartford Insurance Gr's HIG short percent of float has risen 20.74% since its last report. The company recently reported that it has 3.49 million shares sold short, which is 1.63% of all regular shares that are available for trading.

Investors with a lot of money to spend have taken a bullish stance on Sea SE. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Financial giants have made a conspicuous bullish move on Tesla. Our analysis of options history for Tesla TSLA revealed 422 unusual trades. Delving into the details, we found 45% of traders were bullish, while 43% showed bearish tendencies.

Investors with a lot of money to spend have taken a bullish stance on Abercrombie & Fitch ANF. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.

Burlington Stores, Inc. BURL posted better-than-expected earnings for the first quarter on Thursday. The company reported first-quarter adjusted earnings per share of $1.60, beating the analyst consensus estimate of $1.41. Quarterly sales of $2.50 billion missed the Street view of $2.52 billion.

Zscaler reported better-than-expected first-quarter financial results on Thursday after the market closed. Get stock picks, daily rankings, and pro-level trading tools in one powerful platform-Memorial Day sale ending soon. Zscaler, Inc.

Rivian shares face volatility from EV market shifts and proposed tax credit eliminations. However, optimism remains due to the R2 model and strategic partnerships. Rebound or breakdown? See how Matt Maley is trading June's market volatility, live this Wednesday, June 4 at 6 PM ET.

BALA CYNWYD, Pa., May 30, 2025 ( GLOBE NEWSWIRE ) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of TaskUs, Inc. ( "TaskUs" or the "Company" ) ( Nasdaq - TASK ) for possible breaches of fiduciary duty and other violations of ...

The recently spun-off Lionsgate division reported mixed results on Friday morning, but investors were quick to focus on the positive surprises.

Fenebrutinib showed an annualized relapse rate of 0.06 and no disability progression at 96 weeks. T2 lesion rate fell from 6.72 to 0.34 after switching to fenebrutinib in the open-label extension. Rebound or breakdown? See how Matt Maley is trading June's market volatility, live this Wednesday, ...